Why This Matters
When a former president boasts about scoring a perfect 30 out of 30 on a cognitive test, calling it evidence of "extreme intelligence," it's worth pausing. The Montreal Cognitive Assessment (MoCA) is a brief screening tool designed to detect early signs of cognitive decline—not to measure genius. Misunderstanding what this test actually assesses can lead to misplaced confidence, both in public figures and in ourselves. Meanwhile, a rare strain of Ebola is spreading in the Democratic Republic of Congo and Uganda, and the response is raising alarms among global health experts. The intersection of these two stories highlights a critical lesson: accurate health information, transparent communication, and evidence-based action are non-negotiable for public safety.
For health content creators, this is a reminder that science communication matters. When high-profile figures misuse medical terminology, it can skew public understanding. As a researcher, I see this as a teachable moment. Let's break down what the science actually says about cognitive testing, outbreak response, and why transparency in health reporting is essential.
The Science
### The MoCA Test: What It Measures and What It Doesn't
The Montreal Cognitive Assessment is a 30-point test that evaluates several cognitive domains: attention, concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. It's commonly used by clinicians to screen for mild cognitive impairment or early dementia. A score of 26 or above is generally considered normal. A perfect 30 is certainly good, but it doesn't indicate "extreme intelligence." The test was never designed for that purpose.
What the research shows is that the MoCA has high sensitivity (around 90%) for detecting mild cognitive impairment, but it's not a comprehensive neuropsychiatric evaluation. Executive functioning—the ability to plan, organize, inhibit impulses, and make complex decisions under pressure—requires more nuanced testing. A 2019 study in the Journal of Alzheimer's Disease noted that the MoCA is a screening tool, not a diagnostic one. Repeatedly taking the test every four to six weeks, as seems to be the case with President Trump, can also lead to practice effects, where scores improve simply due to familiarity with the test, not because of genuine cognitive improvement.
### The Rare Ebola Strain: A Different Challenge
The current outbreak involves the Sudan strain of Ebola, which is rarer and less studied than the Zaire strain that caused the 2014-2016 West Africa epidemic. Unlike the Zaire strain, there are no licensed vaccines or specific treatments for the Sudan strain. This means management relies on supportive care—hydration, electrolyte balance, and treatment of complications. Diagnostic testing is also more limited, as many existing tests are optimized for the Zaire strain.
A study published in The Lancet Infectious Diseases in 2023 highlighted that the Sudan strain has a case fatality rate ranging from 41% to 100% in previous outbreaks, depending on access to care. The lack of specific medical countermeasures makes early detection and containment even more critical. The World Health Organization has reported 272 confirmed cases and 43 confirmed deaths as of May 30, though suspected cases are likely higher.
Practical Application
For individuals, the key takeaway is to understand the limits of screening tools. If you're concerned about your cognitive health, a single MoCA score is not enough. A comprehensive evaluation by a neurologist or neuropsychologist is necessary. This includes detailed history, imaging, and specialized tests that assess executive function, memory, and processing speed.
In terms of outbreak preparedness, the research is clear: containment begins at the source. Screening at airports is a secondary measure. The most effective strategy is building surveillance and response capacity in outbreak zones. For travelers, the CDC recommends avoiding nonessential travel to affected areas and practicing strict hygiene. If you develop symptoms like fever, severe headache, muscle pain, or unexplained bleeding after travel, seek medical attention immediately and inform your provider of your travel history.
For content creators, the practical application is about accurate framing. When discussing cognitive tests, explain what they are and aren't. Cite studies. Avoid sensationalizing scores. Similarly, when covering outbreaks, emphasize the importance of global health infrastructure. The U.S. military and agencies like USAID have historically played a role in logistics and surveillance. Cuts to these programs can weaken the safety net.
Safety & Considerations
Safety first: If you or a loved one is undergoing cognitive testing, remember that a single test is not a diagnosis. The MoCA can have false positives, especially in people with lower education levels, language barriers, or certain cultural backgrounds. A 2020 review in Neuropsychology Review found that education-adjusted norms improve accuracy but are not always used.
For Ebola, the risk to the general U.S. public remains low. The virus is not airborne; it spreads through direct contact with bodily fluids of infected people or contaminated surfaces. However, healthcare workers and travelers to affected regions are at higher risk. If you're in healthcare, follow CDC guidelines for personal protective equipment and infection control.
A critical safety consideration is the potential for misinformation. When public figures downplay the seriousness of a cognitive test or an outbreak, it can lead to complacency. Always verify health claims with peer-reviewed sources or official health organizations like the WHO or CDC.
Expert Insights
Dr. Vin Gupta, a senior medical analyst and U.S. Air Force Reserve officer, offers a nuanced perspective. He notes that the current administration's withdrawal from global health efforts, including USAID and PEPFAR-funded programs, has weakened diagnostic and surveillance capabilities in the outbreak zone. "The best outbreak response is not at JFK or Dulles. It's in the outbreak zone," he says. The index patient in this outbreak was likely infected weeks before recognition, which is the opposite of what you want.
Regarding the president's health, Dr. Gupta points out that the language used in the official report is not professional. Terms like "AI cardiac age" and explanations for bruising from handshaking are not standard medical terminology. Releasing the report late on a Friday night also undermines transparency. The frequent MoCA testing is unusual and may indicate surveillance for an underlying condition.
What's still debated is the role of cognitive screening in high-stakes leadership. Some experts argue that any cognitive decline, even mild, could impair decision-making. Others say that experience and judgment can compensate. The research is mixed. A 2018 study in The Gerontologist found that cognitive decline in older adults can affect complex decision-making, but the effect varies widely.
Bottom Line
What the science tells us is clear: the MoCA is a screening tool, not a measure of intelligence. Repeated testing can inflate scores. The Sudan Ebola strain is a serious threat that requires a robust global response, and cuts to health infrastructure can have downstream consequences that take months or years to manifest.
For health content creators, this is a reminder to dig deeper. Don't take health claims at face value. Look at the studies. Understand the limitations. Communicate with nuance. The public deserves accurate, evidence-based information—not political spin. Whether you're covering cognitive health or infectious disease, the principles are the same: transparency, accuracy, and a commitment to science.
